These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33823896)

  • 1. TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation.
    Magno L; Bunney TD; Mead E; Svensson F; Bictash MN
    Mol Neurodegener; 2021 Apr; 16(1):22. PubMed ID: 33823896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function - Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation.
    Bull D; Matte JC; Navarron CM; McIntyre R; Whiting P; Katan M; Ducotterd F; Magno L
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166978. PubMed ID: 38061598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
    Magno L; Lessard CB; Martins M; Lang V; Cruz P; Asi Y; Katan M; Bilsland J; Lashley T; Chakrabarty P; Golde TE; Whiting PJ
    Alzheimers Res Ther; 2019 Feb; 11(1):16. PubMed ID: 30711010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Signaling in Neurodegeneration.
    Hammond TR; Marsh SE; Stevens B
    Immunity; 2019 Apr; 50(4):955-974. PubMed ID: 30995509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TREM2 facilitates tau accumulation, spreading, and brain atrophy, but only in the presence of amyloid pathology.
    Haass C
    Neuron; 2021 Apr; 109(8):1243-1245. PubMed ID: 33887187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 expression in the brain and biological fluids in prion diseases.
    Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
    Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia use TAM receptors to detect and engulf amyloid β plaques.
    Huang Y; Happonen KE; Burrola PG; O'Connor C; Hah N; Huang L; Nimmerjahn A; Lemke G
    Nat Immunol; 2021 May; 22(5):586-594. PubMed ID: 33859405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2-mediated activation of microglia breaks link between amyloid and tau.
    Hardy J; Salih D
    Lancet Neurol; 2021 Jun; 20(6):416-417. PubMed ID: 34022161
    [No Abstract]   [Full Text] [Related]  

  • 9. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
    Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
    Front Immunol; 2021; 12():633796. PubMed ID: 33841415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation.
    Iizasa E; Chuma Y; Uematsu T; Kubota M; Kawaguchi H; Umemura M; Toyonaga K; Kiyohara H; Yano I; Colonna M; Sugita M; Matsuzaki G; Yamasaki S; Yoshida H; Hara H
    Nat Commun; 2021 Apr; 12(1):2299. PubMed ID: 33863908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia.
    van der Ende EL; Morenas-Rodriguez E; McMillan C; Grossman M; Irwin D; Sanchez-Valle R; Graff C; Vandenberghe R; Pijnenburg YAL; Laforce R; Ber IL; Lleo A; Haass C; Suarez-Calvet M; van Swieten JC; Seelaar H
    Neurobiol Aging; 2021 Jul; 103():158.e1-158.e5. PubMed ID: 33896652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
    Zhong L; Sheng X; Wang W; Li Y; Zhuo R; Wang K; Zhang L; Hu DD; Hong Y; Chen L; Rao H; Li T; Chen M; Lin Z; Zhang YW; Wang X; Yan XX; Chen X; Bu G; Chen XF
    Immunity; 2023 Aug; 56(8):1794-1808.e8. PubMed ID: 37442133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of TREM receptors.
    Colonna M
    Nat Rev Immunol; 2023 Sep; 23(9):580-594. PubMed ID: 36750615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of TREM2 promotes EMT via the PI3K/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification.
    Li C; Hou X; Yuan S; Zhang Y; Yuan W; Liu X; Li J; Wang Y; Guan Q; Zhou Y
    J Cancer; 2021; 12(11):3277-3290. PubMed ID: 33976737
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia.
    Zhao N; Qiao W; Li F; Ren Y; Zheng J; Martens YA; Wang X; Li L; Liu CC; Chen K; Zhu Y; Ikezu TC; Li Z; Meneses AD; Jin Y; Knight JA; Chen Y; Bastea L; Linares C; Sonustun B; Job L; Smith ML; Xie M; Liu YU; Umpierre AD; Haruwaka K; Quicksall ZS; Storz P; Asmann YW; Wu LJ; Bu G
    J Exp Med; 2022 Dec; 219(12):. PubMed ID: 36107206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
    Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
    Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology.
    Sheng X; Yao Y; Huang R; Xu Y; Zhu Y; Chen L; Zhang L; Wang W; Zhuo R; Can D; Chang CF; Zhang YW; Xu H; Bu G; Zhong L; Chen XF
    J Neuroinflammation; 2021 Dec; 18(1):286. PubMed ID: 34893068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer is associated with inferior outcome in patients with ischemic stroke.
    Seystahl K; Hug A; Weber SJ; Kapitza S; Gramatzki D; Wanner M; Katan M; Luft AR; Rohrmann S; Wegener S; Weller M
    J Neurol; 2021 Nov; 268(11):4190-4202. PubMed ID: 33945004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four diseases, PLAID, APLAID, FCAS3 and CVID and one gene (PHOSPHOLIPASE C, GAMMA-2;
    Kutukculer N; Topyildiz E; Berdeli A; Guven Bilgin B; Aykut A; Durmaz A; Cogulu O; Aksu G; Edeer Karaca N
    Clin Case Rep; 2021 Apr; 9(4):2023-2031. PubMed ID: 33936634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial Function and Regulation during Development, Homeostasis and Alzheimer's Disease.
    Casali BT; Reed-Geaghan EG
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.